Review ■

Neuroprotection in Brain Ischemia: An Update (Part I)

Research output: Contribution to journalReview article

90 Citations (Scopus)

Abstract

Ischemic brain injury produced by stroke or cardiac arrest is a major cause of human neurological disability. Steady advances in the neurosciences have elucidated pathophysiological mechanisms of brain ischemia and have suggested many therapeutic approaches directed at specific injury mechanisms to achieve neuroprotection of the acutely ischemic brain. The first portion of this two-part review highlights the differentiating features and pathological mechanisms of focal and global cerebral ischemic injury and summarizes a wealth of recent evidence as to how antagonism of excitatory amino acid neurotoxicity, mediated via NMDA as well as non-NMDA receptors, may offer a means of diminishing the extent of ischemic injury.

Original languageEnglish (US)
Pages (from-to)95-103
Number of pages9
JournalNeuroscientist
Volume1
Issue number2
DOIs
StatePublished - 1995

Fingerprint

Brain Ischemia
Wounds and Injuries
Excitatory Amino Acids
N-Methylaspartate
Neurosciences
Heart Arrest
Brain Injuries
Stroke
Brain
Neuroprotection
Therapeutics

Keywords

  • Cerebrovascular disease
  • Neuroprotection
  • Stroke

ASJC Scopus subject areas

  • Neuroscience(all)
  • Clinical Neurology

Cite this

Review ■ : Neuroprotection in Brain Ischemia: An Update (Part I). / Ginsberg, Myron.

In: Neuroscientist, Vol. 1, No. 2, 1995, p. 95-103.

Research output: Contribution to journalReview article

@article{8ea4684b56014821bb7f83cf75e76359,
title = "Review ■: Neuroprotection in Brain Ischemia: An Update (Part I)",
abstract = "Ischemic brain injury produced by stroke or cardiac arrest is a major cause of human neurological disability. Steady advances in the neurosciences have elucidated pathophysiological mechanisms of brain ischemia and have suggested many therapeutic approaches directed at specific injury mechanisms to achieve neuroprotection of the acutely ischemic brain. The first portion of this two-part review highlights the differentiating features and pathological mechanisms of focal and global cerebral ischemic injury and summarizes a wealth of recent evidence as to how antagonism of excitatory amino acid neurotoxicity, mediated via NMDA as well as non-NMDA receptors, may offer a means of diminishing the extent of ischemic injury.",
keywords = "Cerebrovascular disease, Neuroprotection, Stroke",
author = "Myron Ginsberg",
year = "1995",
doi = "10.1177/107385849500100206",
language = "English (US)",
volume = "1",
pages = "95--103",
journal = "Neuroscientist",
issn = "1073-8584",
publisher = "SAGE Publications Inc.",
number = "2",

}

TY - JOUR

T1 - Review ■

T2 - Neuroprotection in Brain Ischemia: An Update (Part I)

AU - Ginsberg, Myron

PY - 1995

Y1 - 1995

N2 - Ischemic brain injury produced by stroke or cardiac arrest is a major cause of human neurological disability. Steady advances in the neurosciences have elucidated pathophysiological mechanisms of brain ischemia and have suggested many therapeutic approaches directed at specific injury mechanisms to achieve neuroprotection of the acutely ischemic brain. The first portion of this two-part review highlights the differentiating features and pathological mechanisms of focal and global cerebral ischemic injury and summarizes a wealth of recent evidence as to how antagonism of excitatory amino acid neurotoxicity, mediated via NMDA as well as non-NMDA receptors, may offer a means of diminishing the extent of ischemic injury.

AB - Ischemic brain injury produced by stroke or cardiac arrest is a major cause of human neurological disability. Steady advances in the neurosciences have elucidated pathophysiological mechanisms of brain ischemia and have suggested many therapeutic approaches directed at specific injury mechanisms to achieve neuroprotection of the acutely ischemic brain. The first portion of this two-part review highlights the differentiating features and pathological mechanisms of focal and global cerebral ischemic injury and summarizes a wealth of recent evidence as to how antagonism of excitatory amino acid neurotoxicity, mediated via NMDA as well as non-NMDA receptors, may offer a means of diminishing the extent of ischemic injury.

KW - Cerebrovascular disease

KW - Neuroprotection

KW - Stroke

UR - http://www.scopus.com/inward/record.url?scp=84970313210&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84970313210&partnerID=8YFLogxK

U2 - 10.1177/107385849500100206

DO - 10.1177/107385849500100206

M3 - Review article

VL - 1

SP - 95

EP - 103

JO - Neuroscientist

JF - Neuroscientist

SN - 1073-8584

IS - 2

ER -